InspireMD Inc.InspireMD Inc.InspireMD Inc.

InspireMD Inc.

No trades
See on Supercharts
Market capitalization
‪50.22 M‬USD
−1.17USD
‪−19.92 M‬USD
‪6.21 M‬USD
‪15.70 M‬
Beta (1Y)
2.39

About InspireMD Inc.

CEO
Marvin L. Slosman
Headquarters
Tel Aviv
Employees (FY)
66
Founded
2005
ISIN
US45779A8466
FIGI
BBG000QDM9D4
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NSPR is 2.09 USD — it has decreased by 2.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange InspireMD Inc. stocks are traded under the ticker NSPR.
InspireMD Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
NSPR stock is 3.86% volatile and has beta coefficient of 2.39. Check out the list of the most volatile stocks — is InspireMD Inc. there?
One year price forecast for InspireMD Inc. has a max estimate of 5.20 USD and a min estimate of 4.50 USD.
NSPR earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.14 USD resulting in a −7.14% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about InspireMD Inc. earnings.
InspireMD Inc. revenue for the last quarter amounts to ‪1.56 M‬ USD despite the estimated figure of ‪1.50 M‬ USD. In the next quarter revenue is expected to reach ‪1.63 M‬ USD.
Yes, you can track InspireMD Inc. financials in yearly and quarterly reports right on TradingView.
NSPR stock has fallen by 10.16% compared to the previous week, the month change is a 8.19% fall, over the last year InspireMD Inc. has showed a 107.05% increase.
NSPR net income for the last quarter is ‪−5.41 M‬ USD, while the quarter before that showed ‪−5.18 M‬ USD of net income which accounts for −4.38% change. Track more InspireMD Inc. financial stats to get the full picture.
Today InspireMD Inc. has the market capitalization of ‪50.22 M‬, it has increased by 8.96% over the last week.
No, NSPR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NSPR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InspireMD Inc. stock right from TradingView charts — choose your broker and connect to your account.
NSPR reached its all-time high on Jun 1, 2011 with the price of 75862496.00 USD, and its all-time low was 0.81 USD and was reached on Nov 10, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 66.00 employees. See our rating of the largest employees — is InspireMD Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So InspireMD Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating InspireMD Inc. stock shows the strong sell signal. See more of InspireMD Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on InspireMD Inc. future price: according to them, NSPR price has a max estimate of 5.20 USD and a min estimate of 4.50 USD. Read a more detailed InspireMD Inc. forecast: see what analysts think of InspireMD Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. InspireMD Inc. EBITDA is ‪−20.91 M‬ USD, and current EBITDA margin is −332.88%. See more stats in InspireMD Inc. financial statements.